Home
About
- Who We Are
- Why the Tulip
- What We Do
- How PDBP Works
- Projects We Support
- Analytic Methods for Determining Multimodal Biomarkers for Parkinson's Disease (U18)
- Development of Lewy Bodies Biofluid Signatures by Targeted Proteomics (U18)
- LRRK2 and Other Novel Exosome Proteins in Parkinson's Disease (U18)
- Unbiased Approaches to Novel Biomarker Discovery in Parkinson's Disease (U01)
- Johns Hopkins Medicine Biomarker Discovery in Parkinson's Disease (U01)
- Diagnostic and prognostic biomarkers for Parkinson's disease (U01)
- Multimodal MRI markers of nigrostriatal pathology in Parkinson's disease (U01)
- Biomarkers for early intervention in Parkinson disease (U01)
- Large Scale Biomarker Discovery and Validation for Parkinson's Disease (U01)
- Non-Invasive Markers of Neurodegeneration in Movement Disorders (R01)
- Serotonin and Amyloidopathy (R56)
- Evaluation of glucocerebrosidase pathway biomarkers in Parkinson Disease (U01)
- Data Management Resource
- Glossary